Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology

Jeremy Bordeaux1, Rachel Blitzblau2, Sumaira Z Aasi3

  • 1Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Insights

Dermatofibrosarcoma protuberans (DFSP) is a rare skin cancer. Surgical excision with negative margins is key to minimizing recurrence, though other treatments exist for difficult cases.

Area of Science:

  • Oncology
  • Dermatology
  • Surgical Pathology

Background:

  • Dermatofibrosarcoma protuberans (DFSP) is a rare malignant neoplasm of the skin.
  • DFSP is characterized by extensive local infiltration and a high rate of recurrence.
  • Metastasis is uncommon, but the fibrosarcomatous variant presents an increased risk.

Purpose of the Study:

  • To summarize the key aspects of Dermatofibrosarcoma protuberans (DFSP).
  • To highlight the importance of surgical margins in DFSP treatment.
  • To outline alternative treatment modalities for unresectable or recurrent DFSP.

Main Methods:

  • Review of existing literature on Dermatofibrosarcoma protuberans.
  • Analysis of treatment strategies including surgical excision, radiation therapy, and systemic treatments.
  • Reference to the NCCN Clinical Practice Guidelines for Oncology.

Main Results:

  • Surgical excision with negative margins is the primary treatment for DFSP.
  • Achieving negative margins is crucial for minimizing local recurrence.
  • Radiation therapy and systemic treatments are viable options when complete resection is not feasible.

Conclusions:

  • Dermatofibrosarcoma protuberans requires careful surgical management to prevent recurrence.
  • Aggressive variants like fibrosarcomatous DFSP necessitate prompt and potentially multimodal treatment.
  • Adherence to established guidelines, such as the NCCN Guidelines, ensures optimal patient care.